MounjaroBelmont, CA

Mounjaro in Belmont, CA

For Belmont, California residents, geographic distance from mainland pharmacies has historically affected access to specialty medications. Mounjaro® is the FDA-approved Injectable pen Tirzepatide product manufactured by Eli Lilly; Pacific-region retail pricing varies by pharmacy. Weight Method offers a separate telehealth program: licensed California providers evaluate eligible patients and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program is priced at $329/month uniformly, shipped directly to your Belmont address.

FDA-approved Mounjaro prescribed by licensed providers. Delivered to your door.

Take the Free Quiz

Free consultation · No commitment · Results in weeks

Patient
Patient
Patient
Patient
Patient
4.9/5

From 2,000+ patients · Belmont is already seeing results

Licensed Providers
FDA-Approved Medications
Free Shipping
HIPAA Compliant
Updated May 2026Medically reviewed by licensed providers

Mounjaro in Belmont, CA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Mounjaro to patients in Belmont from $329/month with virtual consultations and direct-to-door shipping.

How does this medication work for weight loss?

Tirzepatide targets the biological mechanisms involved in sustained weight regulation. By activating GLP-1 receptors in the brain, it can reduce hunger signals and slow gastric emptying. Eli Lilly developed Mounjaro® as the FDA-approved Injectable pen product, taken Once weekly, approved in 2022. Weight Method is a separate program: licensed providers in California evaluate eligible patients via telehealth and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program for eligible Belmont, CA residents starts at $329/month.

What treatment options are available locally?

Belmont's suburban communities are hearing more about GLP-1 treatments through word of mouth and national media. Mounjaro® is the FDA-approved Injectable pen Tirzepatide product manufactured by Eli Lilly since 2022. Weight Method's separate program is straightforward: an online assessment, a virtual provider consultation, and compounded Tirzepatide delivered to your Belmont address at $329/month. Compounded Tirzepatide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved.

Ready to Get Started?

Answer a few quick questions to see if you qualify.

Check Eligibility

Your Treatment Options

Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Starting at$199/mo
Semaglutide
Most PopularIn Stock

Semaglutide

Compounded semaglutide. Once-weekly subcutaneous injection.

  • Weekly injection
  • Gradual dose increase
  • Provider monitoring
  • Free shipping
Check Eligibility
Tirzepatide
In Stock

Tirzepatide

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.

  • Weekly injection
  • Dual hormone action
  • Provider monitoring
  • Free shipping
Check Eligibility

Frequently Asked Questions

Weight Method is a telehealth program. You take an online health assessment, a licensed California provider reviews your history and meets with you virtually, and — if appropriate — they prescribe compounded Tirzepatide, which is dispensed by a U.S.-licensed 503A compounding pharmacy and shipped to your Belmont address. The $329/month price covers the medication, the virtual provider consultations, dosing management, and free delivery — there are no hidden fees. Compounded Tirzepatide is not FDA-approved.

Weight Method's compounded Tirzepatide program starts at $329/month in Belmont. That price includes the medication, licensed provider consultations, and free home delivery. We don't bill insurance — there are no copays, no prior authorizations, and no surprise charges. Compounded Tirzepatide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved. Mounjaro® is a separate FDA-approved Injectable pen Tirzepatide product manufactured by Eli Lilly; its retail price varies by pharmacy.

Mounjaro® is the FDA-approved Injectable pen Tirzepatide product manufactured by Eli Lilly. Weight Method prescribes compounded Tirzepatide, which is prepared by a U.S.-licensed 503A compounding pharmacy under state and federal pharmacy regulations. Compounded Tirzepatide is not FDA-approved and is a different regulatory category from FDA-approved finished drug products. Your Weight Method provider will discuss whether compounded Tirzepatide is an appropriate option based on your medical history.

Yes. Weight Method's licensed providers in California can prescribe compounded Tirzepatide through a fully virtual process. You complete an online health assessment, have a virtual consultation, and if approved, your compounded Tirzepatide is shipped directly to your Belmont address. Compounded Tirzepatide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved. There is no need to visit a physical clinic, and the program starts at $329/month.

Mounjaro® is a Injectable pen manufactured by Eli Lilly, FDA-approved since 2022 for Type 2 diabetes. It contains Tirzepatide, which mimics natural incretin hormones to reduce appetite, slow gastric emptying, and help your body regulate hunger. Mounjaro® is taken Once weekly. Weight Method does not sell Mounjaro®; we are a separate program that prescribes compounded Tirzepatide (dispensed by a U.S.-licensed 503A pharmacy and not FDA-approved) starting at $329/month.

Start Your Treatment

Consult with a licensed provider in California and start Mounjaro from $329/month.

Get Started Now

Free consultation. No commitment.

Other Brands in Belmont

Ozempic in BelmontWegovy in BelmontZepbound in BelmontRybelsus in BelmontTirzepatide in Belmont

Nearby Cities

Mounjaro in San Carlos, CAMounjaro in San Mateo, CAMounjaro in Redwood City, CAMounjaro in Burlingame, CA

See More

All About MounjaroTirzepatide in BelmontClinics in Belmont